BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10511429)

  • 1. 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors.
    Chefer SI; Horti AG; Koren AO; Gündisch D; Links JM; Kurian V; Dannals RF; Mukhin AG; London ED
    Neuroreport; 1999 Sep; 10(13):2715-21. PubMed ID: 10511429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
    Sihver W; Fasth KJ; Horti AG; Koren AO; Bergström M; Lu L; Hagberg G; Lundqvist H; Dannals RF; London ED; Nordberg A; Långström B
    J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo.
    Valette H; Bottlaender M; Dollé F; Guenther I; Coulon C; Hinnen F; Fuseau C; Ottaviani M; Crouzel C
    Life Sci; 1999; 64(5):PL93-7. PubMed ID: 10072197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).
    Pichika R; Easwaramoorthy B; Christian BT; Shi B; Narayanan TK; Collins D; Mukherjee J
    Nucl Med Biol; 2011 Nov; 38(8):1183-92. PubMed ID: 21831652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate.
    Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    Nucl Med Biol; 2006 Apr; 33(3):295-304. PubMed ID: 16631077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of a Br-76 analog of epibatidine: a potent ligand for studying brain nicotinic acetylcholine receptors.
    Kassiou M; Bottlaender M; Loc'h C; Dolle F; Musachio JL; Coulon C; Ottaviani M; Dannals RF; Maziere B
    Synapse; 2002 Aug; 45(2):95-104. PubMed ID: 12112402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
    Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
    J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors.
    Horti AG; Chefer SI; Mukhin AG; Koren AO; Gündisch D; Links JM; Kurian V; Dannals RF; London ED
    Life Sci; 2000 Jun; 67(4):463-9. PubMed ID: 11003056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.
    Fujita M; Tamagnan G; Zoghbi SS; Al-Tikriti MS; Baldwin RM; Seibyl JP; Innis RB
    J Nucl Med; 2000 Sep; 41(9):1552-60. PubMed ID: 10994738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography.
    Zhang Y; Pavlova OA; Chefer SI; Hall AW; Kurian V; Brown LL; Kimes AS; Mukhin AG; Horti AG
    J Med Chem; 2004 May; 47(10):2453-65. PubMed ID: 15115389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography.
    Chefer SI; Horti AG; Lee KS; Koren AO; Jones DW; Gorey JG; Links JM; Mukhin AG; Weinberger DR; London ED
    Life Sci; 1998; 63(25):PL355-60. PubMed ID: 9870715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
    Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
    Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons.
    Valette H; Xiao Y; Peyronneau MA; Damont A; Kozikowski AP; Wei ZL; Kassiou M; Kellar KJ; Dollé F; Bottlaender M
    J Nucl Med; 2009 Aug; 50(8):1349-55. PubMed ID: 19652217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
    Iida Y; Ogawa M; Ueda M; Tominaga A; Kawashima H; Magata Y; Nishiyama S; Tsukada H; Mukai T; Saji H
    J Nucl Med; 2004 May; 45(5):878-84. PubMed ID: 15136639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-[I-125/123]lodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors.
    Musachio JL; Scheffel U; Finley PA; Zhan Y; Mochizuki T; Wagner HN; Dannals RF
    Life Sci; 1998; 62(22):PL 351-7. PubMed ID: 9627107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.
    Pichika R; Kuruvilla SA; Patel N; Vu K; Sinha S; Easwaramoorthy B; Narayanan TK; Shi B; Christian B; Mukherjee J
    Nucl Med Biol; 2013 Jan; 40(1):117-25. PubMed ID: 23141552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors.
    Gündisch D; Koren AO; Horti AG; Pavlova OA; Kimes AS; Mukhin AG; London ED
    Synapse; 2005 Feb; 55(2):89-97. PubMed ID: 15529332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.